| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
author index
|
|
|
|
17 |
S3 |
p. iii55-iii57
|
artikel
|
| 2 |
committees
|
|
|
|
17 |
S3 |
p. iii7
|
artikel
|
| 3 |
Editors
|
Giaccone, G.
|
|
|
17 |
S3 |
p. iii1-iii2
|
artikel
|
| 4 |
MDICT Task Force: Methodology for the Development of Innovative Cancer Therapies
|
|
|
|
17 |
S3 |
p. iii6
|
artikel
|
| 5 |
meeting schedule at a glance
|
|
|
|
17 |
S3 |
p. iii8
|
artikel
|
| 6 |
meeting schedule, FRIDAY, MARCH 17, 2006
|
|
|
|
17 |
S3 |
p. iii10-iii14
|
artikel
|
| 7 |
meeting schedule, SATURDAY, MARCH 18, 2006
|
|
|
|
17 |
S3 |
p. iii15-iii16
|
artikel
|
| 8 |
meeting schedule, THURSDAY, MARCH 16, 2006
|
|
|
|
17 |
S3 |
p. iii9
|
artikel
|
| 9 |
plenary session 2: angiogenesis and vascular-targeting agents
|
|
|
|
17 |
S3 |
p. iii20
|
artikel
|
| 10 |
plenary session 3: clinical trial design for targeted agents
|
|
|
|
17 |
S3 |
p. iii21-iii22
|
artikel
|
| 11 |
plenary session 7: immunological targets and mechanisms
|
|
|
|
17 |
S3 |
p. iii28-iii29
|
artikel
|
| 12 |
plenary session 11: miscellaneous agents: preclinical and clinical studies
|
|
|
|
17 |
S3 |
p. iii31-iii33
|
artikel
|
| 13 |
plenary session 8: new technologies and new approaches to targeted cancer therapy
|
|
|
|
17 |
S3 |
p. iii30
|
artikel
|
| 14 |
plenary session 1: opening and keynotes
|
|
|
|
17 |
S3 |
p. iii17-iii19
|
artikel
|
| 15 |
plenary session 5: promising agents targeting downstream signalling pathways
|
|
|
|
17 |
S3 |
p. iii24-iii25
|
artikel
|
| 16 |
plenary session 6: promising agents targeting membrane receptors
|
|
|
|
17 |
S3 |
p. iii26-iii27
|
artikel
|
| 17 |
plenary session 4: targeting apoptosis
|
|
|
|
17 |
S3 |
p. iii23
|
artikel
|
| 18 |
poster session 3: molecular diagnosis, patient selection and prognosis
|
|
|
|
17 |
S3 |
p. iii42-iii46
|
artikel
|
| 19 |
poster session 1: new drug targets, drug design and drug discovery
|
|
|
|
17 |
S3 |
p. iii34-iii36
|
artikel
|
| 20 |
poster session 5: phase I and II studies of new agents
|
|
|
|
17 |
S3 |
p. iii49-iii50
|
artikel
|
| 21 |
poster session 6: post-registration clinical research
|
|
|
|
17 |
S3 |
p. iii51-iii52
|
artikel
|
| 22 |
poster session 2: preclinical drug profiling
|
|
|
|
17 |
S3 |
p. iii37-iii41
|
artikel
|
| 23 |
poster session 4: vaccines, monoclonal antibodies and other immunotherapies
|
|
|
|
17 |
S3 |
p. iii47-iii48
|
artikel
|
| 24 |
subject index
|
|
|
|
17 |
S3 |
p. iii53-iii54
|
artikel
|
| 25 |
Table of Contents
|
|
|
|
17 |
S3 |
p. i
|
artikel
|
| 26 |
TAT 2006 sponsors & grants
|
|
|
|
17 |
S3 |
p. iii4
|
artikel
|
| 27 |
welcome to TAT 2006!
|
|
|
|
17 |
S3 |
p. iii5
|
artikel
|
Tijdschrift beschrijving